SEC Form 4 · accession 0000784199-18-000063
ARTIVION, INC. · AORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott B Capps
Officer — VP, Clinical Research
Period of report
Mar 12, 2018
Accepted (ET)
Mar 14, 2018 · 7:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000784199
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 12, 2018 | A | 3,867 | $0.00 | A | 139,087 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $21.55 | Mar 12, 2018 | A | 9,944 | A | Mar 12, 2019 | Mar 12, 2025 | Common Stock | 9,944 | 9,944 | D |
Explanation of responses
- F1Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company.